{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:43:30Z","timestamp":1785357810332,"version":"3.55.0"},"reference-count":79,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Poliomyelitis Research Foundation (PRF)","award":["N\/a"],"award-info":[{"award-number":["N\/a"]}]},{"name":"Council for Scientific and Industrial Research (CSIR)","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Vaccine efficacy requires the production of neutralising antibodies which offer protection against the native virus. The current gold standard for determining the presence of neutralising antibodies is the pseudovirion-based neutralisation assay (PBNA). PBNAs utilise pseudovirions (PsVs), structures which mimic native virus capsids, but contain non-viral nucleic material. PsVs are currently produced in expensive cell culture systems, which limits their production, yet plant expression systems may offer cheaper, safer alternatives. Our aim was to determine whether plants could be used for the production of functional PsVs of bovine papillomavirus 1 (BPV1), an important causative agent of economically damaging bovine papillomas in cattle and equine sarcoids in horses and wild equids. BPV1 capsid proteins, L1 and L2, and a self-replicating reporter plasmid were transiently expressed in Nicotiana benthamiana to produce virus-like particles (VLPs) and PsVs. Strategies to enhance particle yields were investigated and optimised protocols were established. The PsVs\u2019 ability to infect mammalian cells and express their encapsidated reporter genes in vitro was confirmed, and their functionality as reagents in PBNAs was demonstrated through their neutralisation by several different antibodies. This is the first report of BPV PsVs expressed in plants and demonstrates the potential for the development of therapeutic veterinary vaccines in planta.<\/jats:p>","DOI":"10.3390\/pathogens9120996","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:51:16Z","timestamp":1606535476000},"page":"996","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-4282","authenticated-orcid":false,"given":"Inge","family":"Pietersen","sequence":"first","affiliation":[{"name":"Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertha","family":"van Zyl","sequence":"additional","affiliation":[{"name":"Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-9911","authenticated-orcid":false,"given":"Edward","family":"Rybicki","sequence":"additional","affiliation":[{"name":"Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town 7701, South Africa"},{"name":"Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Hitzeroth","sequence":"additional","affiliation":[{"name":"Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/JVI.01927-09","article-title":"Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches","volume":"84","author":"Campo","year":"2010","journal-title":"J. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1678-4685-gmb-2016-0128","article-title":"Papillomaviruses: A systematic review","volume":"40","author":"Araldi","year":"2017","journal-title":"Genet. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/tbed.12222","article-title":"Bovine Papillomavirus: New Insights into an Old Disease","volume":"63","author":"Bocaneti","year":"2016","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Savini, F., Gallina, L., Prosperi, A., Puleio, R., Lavazza, A., Marco, P.D., Tumino, S., Moreno, A., Lelli, D., and Guercio, A. (2020). Bovine Papillomavirus 1 Gets Out of the Flock: Detection in an Ovine Wart in Sicily. Pathogens, 9.","DOI":"10.3390\/pathogens9060429"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1038\/s41598-018-31529-9","article-title":"Oral fibropapillomatosis and epidermal hyperplasia of the lip in newborn lambs associated with bovine Deltapapillomavirus","volume":"8","author":"Roperto","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tvjl.2013.11.025","article-title":"Papillomaviruses in felids","volume":"199","author":"Munday","year":"2014","journal-title":"Vet. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1177\/0300985810391111","article-title":"Cutaneous Sarcoids in Captive African Lions Associated With Feline Sarcoid-Associated Papillomavirus Infection","volume":"48","author":"Orbell","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4102\/jsava.v82i2.42","article-title":"Pathology and immunohistochemistry of papillomavirus-associated cutaneous lesions in Cape mountain zebra, giraffe, sable antelope and African buffalo in South Africa","volume":"82","author":"Williams","year":"2011","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4102\/jsava.v82i2.39","article-title":"Detection and characterisation of papillomavirus in skin lesions of giraffe and sable antelope in South Africa","volume":"82","author":"Bosman","year":"2011","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1354\/vp.08-VP-0222-P-FL","article-title":"Bovine Papillomavirus Type 1 DNA and E5 Oncoprotein Expression in Water Buffalo Fibropapillomas","volume":"46","author":"Silvestre","year":"2009","journal-title":"Vet. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1099\/vir.0.047662-0","article-title":"Communication Bovine papillomavirus type 2 infects the urinary bladder of water buffalo (Bubalus bubalis) and plays a crucial role in bubaline urothelial carcinogenesis","volume":"94","author":"Roperto","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1865-1682.2009.01096.x","article-title":"Detection of BPV-1 and -2 and Quantification of BPV-1 by Real-Time PCR in Cutaneous Warts in Cattle and Buffaloes","volume":"57","author":"Pangty","year":"2010","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0168-1702(02)00193-4","article-title":"Animal models of papillomavirus pathogenesis","volume":"89","author":"Campo","year":"2002","journal-title":"Virus Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.2042-3292.2012.00411.x","article-title":"A review of equine sarcoid","volume":"25","author":"Taylor","year":"2013","journal-title":"Equine Vet. Educ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/JCM.00371-13","article-title":"Bovine Papillomavirus Type 13 DNA in Equine Sarcoids","volume":"51","author":"Lunardi","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","first-page":"105","article-title":"Preliminary binary ethylenimine (BEI) inactivated bovine papillomavirus (BPV) vaccine trial against cutaneous warts in bull calves : A pathological assessment","volume":"3","author":"Pangty","year":"2010","journal-title":"Braz. J. Vet. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.15547\/tjs.2015.s.02.061","article-title":"Papillomatosis in heifers\u2014Comparative studies on Surgical excision and autogenous vaccine therapies","volume":"13","author":"Terziev","year":"2015","journal-title":"Trakia J. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kale, M., Saltik, H.S., Hasircioglu, S., Yildirim, Y., Yavru, S., Mamak, N., and Atli, K. (2019). Treatment of Bovine papillomavirus-induced teat warts in a cow by using Podophyllin magistral formula and autologous vaccine applications together. Indian J. Anim. Res., 832\u2013836.","DOI":"10.18805\/ijar.B-911"},{"key":"ref_19","first-page":"709","article-title":"Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009\u20132014)","volume":"56","author":"Rothacker","year":"2014","journal-title":"Can. Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rvsc.2011.10.018","article-title":"Virus-like particles: Potential veterinary vaccine immunogens","volume":"93","author":"Liu","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cimid.2013.02.002","article-title":"Virus-like particles: Promising platforms with characteristics of DIVA for veterinary vaccine design","volume":"36","author":"Liu","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.1996.0220","article-title":"Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization","volume":"219","author":"Kirnbauer","year":"1996","journal-title":"Virology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0738-081X(96)00165-4","article-title":"Vaccination against papillomavirus in cattle","volume":"15","author":"Campo","year":"1997","journal-title":"Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1099\/vir.0.033670-0","article-title":"Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCS prior to pseudo-sarcoid formation","volume":"92","author":"Hartl","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.07.036","article-title":"Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes","volume":"393","author":"Schellenbacher","year":"2009","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/0022-1317-77-7-1577","article-title":"Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies","volume":"77","author":"Gaukroger","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_28","first-page":"1017","article-title":"The Challenges Inherent in the Control and Prevention of Bovine Papillomaviruses","volume":"3","author":"Mariz","year":"2016","journal-title":"Austin J. Genet. Genom. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bayer, L., Gumpel, J., Hause, G., Muller, M., and Grunwald, T. (2018). Non-human papillomaviruses for gene delivery in vitro and in vivo. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198996"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kines, R.C., Zarnitsyn, V., Johnson, T.R., Pang, Y.S., Corbett, K.S., Nicewonger, J.D., Gangopadhyay, A., Chen, M., and Liu, J. (2015). Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120797"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.omtm.2017.04.005","article-title":"Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions","volume":"5","author":"Cerqueira","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/JVI.78.2.751-757.2004","article-title":"Efficient Intracellular Assembly of Papillomaviral Vectors","volume":"78","author":"Buck","year":"2004","journal-title":"J. Virol."},{"key":"ref_33","first-page":"445","article-title":"Generation of HPV pseudovirions using transfection and their use in neutralization assays","volume":"119","author":"Buck","year":"2005","journal-title":"Methods Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","article-title":"Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18","volume":"321","author":"Pastrana","year":"2004","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/hv.27619","article-title":"Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination","volume":"10","author":"Zhao","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/hv.3.4.4058","article-title":"Antibodies from women immunized with Gardasil\u00ae cross-neutralize HPV 45 pseudovirions","volume":"3","author":"Smith","year":"2007","journal-title":"Hum. Vaccin."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sehr, P., Rubio, I., Seitz, H., Putzker, K., Ribeiro-M\u00fcller, L., Pawlita, M., and M\u00fcller, M. (2013). High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075677"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.vaccine.2017.11.034","article-title":"Comparative immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9\u201314 years: Results to month 36 from a randomized trial","volume":"36","author":"Leung","year":"2018","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1006\/viro.2000.0674","article-title":"Neutralization of human papillomavirus (HPV) pseudovirions: A novel and efficient approach to detect and characterize HPV neutralizing antibodies","volume":"278","author":"Yeager","year":"2000","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(15)00414-3","article-title":"Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: A multicentre prospective cohort study","volume":"17","author":"Sankaranarayanan","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum. Vaccin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pvr.2017.02.005","article-title":"A novel trivalent HPV 16\/18\/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model","volume":"3","author":"Yin","year":"2017","journal-title":"Papillomavirus Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"100353","DOI":"10.1016\/j.eclinm.2020.100353","article-title":"Immunogenicity and safety of the AS04-HPV-16\/18 and HPV-6\/11\/16\/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15\u201325 years: A phase IV randomized comparative study","volume":"23","author":"Folschweiller","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1099\/jgv.0.000673","article-title":"Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2- induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse","volume":"98","author":"Hainisch","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/bfgp\/ely020","article-title":"Vaccine and antibody production in plants : Developments and computational tools","volume":"17","author":"Dubey","year":"2018","journal-title":"Brief. Funct. Genom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12985-014-0205-0","article-title":"Plant-based vaccines against viruses","volume":"11","author":"Rybicki","year":"2014","journal-title":"Virol. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00425-012-1692-0","article-title":"In planta production of a candidate vaccine against bovine papillomavirus type 1","volume":"236","author":"Love","year":"2012","journal-title":"Planta"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zahin, M., Joh, J., Khanal, S., Husk, A., Mason, H., Warzecha, H., Ghim, S.J., Miller, D.M., Matoba, N., and Jenson, A.B. (2016). Scalable production of HPV16 L1 protein and VLPs from tobacco leaves. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160995"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.2174\/1381612811319310011","article-title":"The Use of Transient Expression Systems for the Rapid Production of Virus-like Par- ticles in Plants","volume":"19","author":"Thuenemann","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_50","first-page":"20431","article-title":"Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells","volume":"6","author":"Lamprecht","year":"2016","journal-title":"Nat. Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1467-7652.2011.00671.x","article-title":"Comparative analysis of recombinant Human Papillomavirus 8L1 production in plants by a variety of expression systems and purification methods","volume":"10","author":"Masenga","year":"2012","journal-title":"Plant Biotechnol. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0006-3495(91)82181-6","article-title":"Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction","volume":"60","author":"Baker","year":"1991","journal-title":"Biophys. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/jmbi.1996.0317","article-title":"Conserved features in papillomavirus and polyomavirus capsids","volume":"259","author":"Belnap","year":"1996","journal-title":"J. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e00128-19","DOI":"10.1128\/JVI.00128-19","article-title":"Phosphorylation of human papillomavirus type 16 L2 contributes to efficient virus infectious entry","volume":"93","author":"Broniarczyk","year":"2019","journal-title":"J. Virol."},{"key":"ref_55","unstructured":"Sweke, R. (2020, November 26). Particle Counter, GitHub, 2017. Available online: https:\/\/github.com\/CorrieGunter\/particle_counter."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13007-018-0343-2","article-title":"Improving agroinfiltration\u2014Based transient gene expression in Nicotiana benthamiana","volume":"14","author":"Norkunas","year":"2018","journal-title":"Plant Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/599988","article-title":"Immunogenicity Testing in Human Papillomavirus Virus-Like-Particle Vaccine Trials","volume":"200","author":"Schiller","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/CVI.00292-07","article-title":"Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing Pseudovirions","volume":"15","author":"Fleury","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14760584.2016.1157479","article-title":"Progress and prospects for L2-based human papillomavirus vaccines","volume":"15","author":"Jiang","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"10493","DOI":"10.1128\/JVI.75.21.10493-10497.2001","article-title":"Positively Charged Termini of the L2 Minor Capsid Protein Are Necessary for Papillomavirus Infection","volume":"75","author":"Roden","year":"2001","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0042-6822(91)90819-W","article-title":"Studies on Vaccination against Papillomaviruses: Prophylactic and Therapeutic Vaccination with Recombinant Structural Proteins","volume":"184","author":"Jarrett","year":"1991","journal-title":"Virology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1128\/JVI.79.5.2839-2846.2005","article-title":"Maturation of Papillomavirus Capsids","volume":"79","author":"Buck","year":"2005","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.copbio.2014.12.018","article-title":"High-value products from plants: The challenges of process optimization","volume":"32","author":"Fischer","year":"2015","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.virol.2004.04.034","article-title":"In vitro papillomavirus capsid assembly analyzed by light scattering","volume":"325","author":"Casini","year":"2004","journal-title":"Virology"},{"key":"ref_65","unstructured":"Adams, A. (2020). Optimization and Characterisation of Plant Produced Human Papillomavirus Pseudovirions in Nicotiana Benthamiana. [Master\u2019s Thesis, University of Cape Town]."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1006\/viro.1998.9091","article-title":"DNA Packaging by L1 and L2 Capsid Proteins of Bovine Papillomavirus Type 1","volume":"243","author":"Zhao","year":"1998","journal-title":"Virology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/viro.2000.0348","article-title":"BPV1 E2 Protein Enhances Packaging of Full-Length Plasmid DNA in BPV1 Pseudovirions","volume":"272","author":"Zhao","year":"2000","journal-title":"Virology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(93)90136-B","article-title":"Monoclonal antibody neutralization of BPV-1","volume":"28","author":"Christensen","year":"1993","journal-title":"Virus Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1099\/vir.0.82718-0","article-title":"Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: Comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization","volume":"88","author":"Maclean","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s11105-013-0614-z","article-title":"Comparison of Expression Vectors for Transient Expression of Recombinant Proteins in Plants","volume":"31","author":"Shah","year":"2013","journal-title":"Plant Mol. Biol. Report."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1038\/s41598-018-27778-3","article-title":"A conditional silencing suppression system for transient expression","volume":"8","author":"Reis","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pbi.12802","article-title":"LALF 32-51-E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in Nicotiana benthamiana leaves","volume":"16","author":"Yanez","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"ref_73","first-page":"440","article-title":"Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells","volume":"19","author":"Soboleski","year":"2005","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-59745-559-6_19","article-title":"Use of GFP to investigate expression of plant-derived vaccines","volume":"515","author":"Li","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2144\/97235bi01","article-title":"Applications of Green Fluorescent Protein in Plants","volume":"23","author":"Leffel","year":"1997","journal-title":"BioTechniques"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals","volume":"8","author":"Rybicki","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"ref_77","unstructured":"NIAID Office of Cyber Infrastructure and Computational Biology (2020, November 26). PaVE: Papilloma Virus Genome Database, Available online: http:\/\/pave.niaid.nih.gov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1467-7652.2009.00462.x","article-title":"High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector: Protein expression in plants utilizing BeYDV","volume":"8","author":"Regnard","year":"2010","journal-title":"Plant Biotechnol. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/viro.1996.0466","article-title":"Surface Conformational and Linear Epitopes on HPV-16 and HPV-18 L1 Virus-like Particles as Defined by Monoclonal Antibodies","volume":"184","author":"Christensen","year":"1996","journal-title":"Virology"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/9\/12\/996\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:38:46Z","timestamp":1760179126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/9\/12\/996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["pathogens9120996"],"URL":"https:\/\/doi.org\/10.3390\/pathogens9120996","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]}}}